Prism™ for PTSD
Prism™ by GrayMatters Health is an evidence-based, prescription therapy, FDA-cleared to treat PTSD. During Prism sessions, a computer simulation and soft EEG cap create an environment where patients engage in a non-trauma-based experience to help them learn to control their PTSD symptoms.
Prism is the first PTSD treatment based on a digital fMRI-Informed biomarker associated with mental health disorders. Read more about the technology behind Prism for PTSD.
PRISM REGIMEN
15 sessions, over 8 weeks or
as determined by healthcare provider.
Booster sessions as needed.
Each session lasts about 45 minutes.
PROVEN CLINICAL OUTCOMES
Clinical studies and real-world experience have demonstrated significant improvement in PTSD symptoms with a high safety profile.
OPERATIONAL SIMPLICITY
All you need is a quiet room, table, chair and trained Prism Operator. Read a Case Study of a Community Clinic in Texas.
PERSONALIZED CARE
Patients explore mental strategies - a personal memory, emotion or experience - that gets the animated characters in the Prism simulation to
sit down and lower their voices.
YOUR PARTNER
A dedicated GrayMatters Health Account Manager will be your co-pilot to help build a Prism service at your Interventional Psychiatry practice.
The Prism for PTSD multi-center clinical study demonstrated the following results
3 months after the 15-session regimen (5 months from baseline):
-
67% of patients overall demonstrated clinically significant symptom improvement
as measured by CAPS-5. -
Significant improvement in sleep, as measured by PHQ-9 and CAPS-5.
-
32% of patients experienced remission.
-
90% patient compliance.
-
Mild side effects, such as fatigue and headache, resolved after treatment
with no further intervention.
Fruchter et al. Psychiatry Research 333 (2024), 115711.